Coronavirus Vaccine: Bangavax and two other vaccines to meet human trial conditions
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Sunday
January 29, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SUNDAY, JANUARY 29, 2023
Bangavax and two other vaccines to meet human trial conditions

Covid-19 in Bangladesh

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Bangavax and two other vaccines to meet human trial conditions

Globe Biotech and two Indian and Chinese drugmakers must submit documents on the effectiveness and side effects of the vaccines on monkeys

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm
Logo of Globe Biotech Limited. Picture: Collected
Logo of Globe Biotech Limited. Picture: Collected

The Bangladesh Medical Research Council (BMRC) has set conditions for the human trial of three more coronavirus vaccines, including local drugmaker Globe Biotech's Bangavax, and two others from China and India respectively.

Before "human trials", the institutes will have to fulfil all conditions as per BMRC rules.

The decision was made at a meeting of the National Research Ethics Committee of the BMRC on Wednesday morning.

"We have decided in principle to approve the three vaccines. But they must meet certain conditions," BMRC Director, Professor Dr Ruhul Amin, told journalists after the meeting.

"All documents on the effectiveness and side effects of these vaccines on monkeys or chimpanzees must be submitted to the BMRC prior to Phase-1 trials. The issue of safety in human use will be seriously considered. If these rules are followed, we will definitely approve."

In addition to Bangavax, it has been decided in principle to approve the applications of Bharat Biotech and the Vero cell vaccine by the Institute of Medical Biology, Chinese Academy of Medical Sciences.

Two icddr,b scientists sought approval for the Chinese and Indian vaccines, and Globe Biotech for Bangavax.

Dr Ruhul Amin said, "It is not that the Globe vaccine has received approval for a clinical trial. But we are positive, even though several issues have been raised, including safety issues."

He said the three companies that have applied for first and second phase clinical trials will be informed of the Bangladesh Medical Research Council's (BMRC) decision.

"If necessary, the Contract Research Organisations (CROs) of the three companies can be called at any time to know the current status of the institutes," he added.

On 28 December, Globe Biotech, a Bangladeshi biotech firm, got approval from the Directorate General of Drug Administration (DGDA) to produce Covid-19 vaccine candidate Bangavax to carry out clinical trials.

On 16 January it submitted its trial protocol to the BMRC for the clinical trials of its Covid-19 vaccine, Bangavax.

Earlier, the company on 5 October 2020, noted that vaccine trials on rabbits and mice had shown "very promising results."

Bangladesh has so far approved the emergency use of six vaccines – Oxford-AstraZeneca, Sinopharm of China, Sputnik-V of Russia, Pfizer-BioNTech, CronaVac of China, and Johnson & Johnson.

Bangladesh / Top News

BMRC / conditonally / approves / human trial / Bangavax

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Getting gas to India will be even more costly than laying this pipe to China.Photographer: Andrey Rudakov/Bloomberg
    Russia can't replace the energy market Putin broke
  • Photo: UNB
    AL won't run away, rather will continue developing Bangladesh: PM in Rajshahi
  • Reconditioned vehicles running out of stock as traders fail to open LCs
    Reconditioned vehicles running out of stock as traders fail to open LCs

MOST VIEWED

  • Incepta Pharma abandons Covid vaccine plan
    Incepta Pharma abandons Covid vaccine plan
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    Tighter screening at ports urged as new Covid sub-variant BF.7 detected
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    First case of new Covid sub-variant Omicron BF.7 detected in Bangladesh: IEDCR
  • Illustration: Collected
    Genome sequencing reports of Chinese nationals infected with Covid by Sunday: IEDCR
  • Computer image of a betacoronavirus which is the type of virus linked to Covid-19
    4 Chinese nationals detected with Covid at Dhaka airport
  • Omicron BF7: Land ports still left unguarded
    Omicron BF7: Land ports still left unguarded

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

5h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

9h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

8h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

9m | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

1h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

22h | TBS Entertainment
15 Reasons Your Entrepreneurial Career Can Fail

15 Reasons Your Entrepreneurial Career Can Fail

21h | TBS Career

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]